data_1rpb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rpb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 . -150.12 137.268 -72.847 108.717 2.0 110.639 -73.353 -167.571 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . 0.338 1.0 OUTLIER -130.64 -174.85 3.47 Favored 'General case' 0 CA--C 1.583 2.237 0 C-N-CA 124.546 1.138 . . . . 0.0 110.942 167.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.72 39.62 2.82 Favored Glycine 0 N--CA 1.506 3.355 0 N-CA-C 119.397 2.519 . . . . 0.0 119.397 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.312 1.6 tp -79.42 -142.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.228 0 CA-C-N 118.329 1.065 . . . . 0.0 113.504 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.64 59.96 0.27 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 119.908 2.723 . . . . 0.0 119.908 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t -127.08 -65.75 0.93 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 171.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 p -139.58 -158.15 0.83 Allowed 'General case' 0 CA--C 1.578 2.03 0 O-C-N 121.009 -1.057 . . . . 0.0 112.358 -177.94 42.713 -150.622 -84.295 107.904 1.996 107.09 -47.326 -59.753 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -111.19 141.64 44.43 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.226 -1.546 . . . . 0.0 111.411 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.313 40.7 p30 -77.27 -72.31 0.36 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.316 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -142.99 81.63 1.73 Allowed 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 120.24 1.382 . . . . 0.0 113.518 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 60.25 76.18 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.29 -12.78 18.24 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 119.973 2.749 . . . . 0.0 119.973 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.3 t -68.54 -37.94 80.4 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -177.075 -167.571 -73.353 -72.847 110.639 2.0 108.717 137.268 -150.12 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.04 -133.49 2.47 Favored Glycine 0 N--CA 1.487 2.06 0 O-C-N 121.068 -1.02 . . . . 0.0 113.591 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -113.44 166.82 11.12 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -171.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.54 143.28 23.71 Favored 'General case' 0 CA--C 1.561 1.37 0 O-C-N 120.723 -1.236 . . . . 0.0 111.065 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.21 -42.34 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.562 -0.712 . . . . 0.0 111.382 168.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -90.72 106.04 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.7 m -70.0 112.57 6.49 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -172.463 -59.753 -47.326 -84.295 107.09 1.996 107.904 -150.622 42.713 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -69.42 -28.15 65.89 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 125.101 2.381 . . . . 0.0 111.079 171.925 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 . -150.12 137.268 -72.847 108.717 2.0 110.639 -73.353 -167.571 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . 0.338 1.0 OUTLIER -130.64 -174.85 3.47 Favored 'General case' 0 CA--C 1.583 2.237 0 C-N-CA 124.546 1.138 . . . . 0.0 110.942 167.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.72 39.62 2.82 Favored Glycine 0 N--CA 1.506 3.355 0 N-CA-C 119.397 2.519 . . . . 0.0 119.397 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.312 1.6 tp -79.42 -142.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.228 0 CA-C-N 118.329 1.065 . . . . 0.0 113.504 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.64 59.96 0.27 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 119.908 2.723 . . . . 0.0 119.908 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t -127.08 -65.75 0.93 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 171.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 p -139.58 -158.15 0.83 Allowed 'General case' 0 CA--C 1.578 2.03 0 O-C-N 121.009 -1.057 . . . . 0.0 112.358 -177.94 42.713 -150.622 -84.295 107.904 1.996 107.09 -47.326 -59.753 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -111.19 141.64 44.43 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.226 -1.546 . . . . 0.0 111.411 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.313 40.7 p30 -77.27 -72.31 0.36 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.316 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -142.99 81.63 1.73 Allowed 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 120.24 1.382 . . . . 0.0 113.518 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 60.25 76.18 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.29 -12.78 18.24 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 119.973 2.749 . . . . 0.0 119.973 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.3 t -68.54 -37.94 80.4 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -177.075 -167.571 -73.353 -72.847 110.639 2.0 108.717 137.268 -150.12 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.04 -133.49 2.47 Favored Glycine 0 N--CA 1.487 2.06 0 O-C-N 121.068 -1.02 . . . . 0.0 113.591 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -113.44 166.82 11.12 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -171.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.54 143.28 23.71 Favored 'General case' 0 CA--C 1.561 1.37 0 O-C-N 120.723 -1.236 . . . . 0.0 111.065 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.21 -42.34 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.562 -0.712 . . . . 0.0 111.382 168.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -90.72 106.04 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.7 m -70.0 112.57 6.49 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -172.463 -59.753 -47.326 -84.295 107.09 1.996 107.904 -150.622 42.713 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -69.42 -28.15 65.89 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 125.101 2.381 . . . . 0.0 111.079 171.925 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 . -150.12 137.268 -72.847 108.717 2.0 110.639 -73.353 -167.571 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . 0.338 1.0 OUTLIER -130.64 -174.85 3.47 Favored 'General case' 0 CA--C 1.583 2.237 0 C-N-CA 124.546 1.138 . . . . 0.0 110.942 167.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.72 39.62 2.82 Favored Glycine 0 N--CA 1.506 3.355 0 N-CA-C 119.397 2.519 . . . . 0.0 119.397 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.312 1.6 tp -79.42 -142.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.228 0 CA-C-N 118.329 1.065 . . . . 0.0 113.504 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.64 59.96 0.27 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 119.908 2.723 . . . . 0.0 119.908 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t -127.08 -65.75 0.93 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 171.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 p -139.58 -158.15 0.83 Allowed 'General case' 0 CA--C 1.578 2.03 0 O-C-N 121.009 -1.057 . . . . 0.0 112.358 -177.94 42.713 -150.622 -84.295 107.904 1.996 107.09 -47.326 -59.753 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -111.19 141.64 44.43 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.226 -1.546 . . . . 0.0 111.411 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.313 40.7 p30 -77.27 -72.31 0.36 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.316 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -142.99 81.63 1.73 Allowed 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 120.24 1.382 . . . . 0.0 113.518 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 60.25 76.18 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.29 -12.78 18.24 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 119.973 2.749 . . . . 0.0 119.973 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.3 t -68.54 -37.94 80.4 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -177.075 -167.571 -73.353 -72.847 110.639 2.0 108.717 137.268 -150.12 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.04 -133.49 2.47 Favored Glycine 0 N--CA 1.487 2.06 0 O-C-N 121.068 -1.02 . . . . 0.0 113.591 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -113.44 166.82 11.12 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -171.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.54 143.28 23.71 Favored 'General case' 0 CA--C 1.561 1.37 0 O-C-N 120.723 -1.236 . . . . 0.0 111.065 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.21 -42.34 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.562 -0.712 . . . . 0.0 111.382 168.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -90.72 106.04 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.7 m -70.0 112.57 6.49 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -172.463 -59.753 -47.326 -84.295 107.09 1.996 107.904 -150.622 42.713 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -69.42 -28.15 65.89 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 125.101 2.381 . . . . 0.0 111.079 171.925 . . . . . . . . 0 0 . 1 stop_ save_